These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8962263)

  • 21. The protective effect of CD8+CD28- T suppressor cells on the acute rejection responses in rat liver transplantation.
    Liu Y; Chen N; Chen G; You P
    Transplant Proc; 2007 Dec; 39(10):3396-403. PubMed ID: 18089392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation.
    Yurovsky VV; Cottler-Fox MH; Atamas SP; Shanholtz CB; Britt EJ; Sensenbrenner LL; White B
    Am J Hematol; 2001 Jan; 66(1):1-11. PubMed ID: 11426485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of in vivo blockade of interleukin-1 and interferon-gamma on the autoimmune syndrom in the experimental model of graft versus host disease].
    Ejedus L; Stosić-Grujicić S; Lukić M
    Srp Arh Celok Lek; 1994; 122 Suppl 1():15-7. PubMed ID: 18173176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.
    Okamoto I; Iwaki K; Koya-Miyata S; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Clin Immunol; 2002 May; 103(2):132-44. PubMed ID: 12027418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
    Schneider M; Munder M; Karakhanova S; Ho AD; Goerner M
    Clin Lab Haematol; 2006 Dec; 28(6):382-90. PubMed ID: 17105491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Runt syndrome incidence and skin graft tolerance in various interstrain combinations of rats differing at a single or multiple histocompatibility loci.
    Kren V; Krenová D; Stark O
    Folia Biol (Praha); 1970; 16(5):305-13. PubMed ID: 4921105
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoimmunity in chronic graft-versus-host disease.
    Fialkow PJ; Gilchrist C; Allison AC
    Clin Exp Immunol; 1973 Apr; 13(4):479-86. PubMed ID: 4123818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces.
    Czaja AJ
    Lab Invest; 1994 May; 70(5):589-92. PubMed ID: 7910872
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoimmune hyperthyroidism associated with chronic graft-versus-host disease.
    Mulligan SP; Joshua DE; Joasoo A; Kronenberg H
    Transplantation; 1987 Sep; 44(3):463-4. PubMed ID: 3307069
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronologic alteration of suppressive effects of serum from liver-grafted rats against graft versus host disease.
    Enoki T; Goto S; Kamada N; Hayashi D; Esato K
    Transplant Proc; 1998 Nov; 30(7):3258-9. PubMed ID: 9838440
    [No Abstract]   [Full Text] [Related]  

  • 35. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 36. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats.
    Masubuchi Y; Kawaguchi T; Ohtsuki M; Suzuki C; Amano Y; Hoshino Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1064-5. PubMed ID: 8623228
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of natural killer cells in lethal graft-versus-host disease in rat models.
    Akioka K; Nakajima H; Fujiwara I; Mastuda T; Arakawa K; Oka T
    Transplant Proc; 1997; 29(1-2):722-4. PubMed ID: 9123498
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatitis induced by the graft-versus-host reaction.
    Walters MN
    J Pathol Bacteriol; 1966 Jan; 91(1):65-9. PubMed ID: 5941402
    [No Abstract]   [Full Text] [Related]  

  • 39. Bearing certain tumors may result in autoimmunity.
    Witz IP; Cahalon L; Smorodinsky NI; Ran M
    Isr J Med Sci; 1988 Dec; 24(12):744-6. PubMed ID: 2465285
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous "autoimmune disease" in nude mice.
    Morse HC; Steinberg AD; Schur PH; Reed ND
    J Immunol; 1974 Aug; 113(2):688-97. PubMed ID: 4602664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.